Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid
Authors:
- Liam D. AubreyLALiam D. Aubrey
- Natalia NinkinaNNNatalia Ninkina
- Natalia Y. AbramychevaNANatalia Y. Abramycheva
- Eftychia VasiliEVEftychia Vasili
- Martin WilkinsonMWMartin Wilkinson
- Eilish MackinnonEMEilish Mackinnon
- Galina LimorenkoGLGalina Limorenko
- Martin WalkoMWMartin Walko
- Leonardo AmadioLALeonardo Amadio
Open Access
- 3 January 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (2)
Abstract
α-, β-, and γ-Synuclein are intrinsically disordered proteins implicated in physiological processes in the nervous system of vertebrates. α-synuclein (αSyn) is the amyloidogenic protein associated with Parkinson’s disease and certain other neurodegenerative disorders. Intensive research has focused on the mechanisms that cause αSyn to form amyloid structures, identifying its NAC region as being necessary and sufficient for amyloid assembly. Recent work has shown that a 7-residue sequence (P1) is necessary for αSyn amyloid formation. Although γ-synuclein (γSyn) is 55% identical in sequence to αSyn and its pathological deposits are also observed in association with neurodegenerative conditions, γSyn is resilient to amyloid formation in vitro. Here, we report a rare single nucleotide polymorphism (SNP) in the SNCG gene encoding γSyn, found in two patients with amyotrophic lateral sclerosis (ALS). The SNP results in the substitution of Met38 with Ile in the P1 region of the protein. These individuals also had a second, common and nonpathological, SNP in SNCG resulting in the substitution of Glu110 with Val. In vitro studies demonstrate that the Ile38 variant accelerates amyloid fibril assembly. Contrastingly, Val110 retards fibril assembly and mitigates the effect of Ile38. Substitution of residue 38 with Leu had little effect, while Val retards, and Ala increases the rate of amyloid formation. Ile38 γSyn also results in the formation of γSyn-containing inclusions in cells. The results show how a single point substitution can enhance amyloid formation of γSyn and highlight the P1 region in driving amyloid formation in another synuclein family member.Keywords
Funding Information
- Wellcome Trust (204963)
- Wellcome Trust (221524/Z/20/Z)
- Royal Society (RSRP/R1/211057)
- UKRI | Medical Research Council (MR/T011149/1)
- UKRI | Biotechnology and Biological Sciences Research Council (BB/V003577/1)
- UKRI | Engineering and Physical Sciences Research Council (EP/N013573/1)
- UKRI | Biotechnology and Biological Sciences Research Council (BB/T011157/1)
- Deutsche Forschungsgemeinschaft (2067/1- 390729940)
- ministry of science Russian Federation (075-15-2021-1346)
- UKRI | MRC | Medical Research Foundation (MC/PC/16030/2)
This publication has 104 references indexed in Scilit:
- Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosisNeurobiology of Disease, 2012
- Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-SynucleinJournal of Molecular Biology, 2011
- The A53T Mutation is Key in Defining the Differences in the Aggregation Kinetics of Human and Mouse α-SynucleinJournal of the American Chemical Society, 2011
- Conformational Conversion during Amyloid Formation at Atomic ResolutionMolecular Cell, 2011
- Differential Phospholipid Binding of α-Synuclein Variants Implicated in Parkinson’s Disease Revealed by Solution NMR SpectroscopyBiochemistry, 2010
- Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease modelsThe EMBO Journal, 2009
- The Zyggregator method for predicting protein aggregation propensitiesChemical Society Reviews, 2008
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998